V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20178722 | 20066579 | null | null | Curative (C) | 2016-10-05 | 2016-10-24 | FLUOROURACIL | 2 | N | FLUOROURACIL | 100420073 |
| 20178728 | 20066580 | 1.69 | 77.4 | Adjuvant (A) | 2017-01-25 | 2017-02-28 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 100818955 |
| 20178736 | 20066581 | 1.81 | 62.6 | Neo-adjuvant (N) | 2017-04-06 | 2017-04-15 | FLUOROURACIL | 02 | Y | FLUOROURACIL | 101748465 |
| 20178738 | 20066582 | 1.83 | 86 | Palliative (P) | 2019-11-02 | 2019-11-09 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101320710 |
| 20178739 | 20066583 | 1.99 | 65.3 | Adjuvant (A) | 2018-02-27 | 2018-03-07 | FLUOROURACIL | 02 | Y | FLUOROURACIL | 101646475 |
| 20178741 | 20066584 | 1.64 | 55 | 03 | 2017-12-21 | 2018-01-03 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101733396 |
| 20178743 | 20066585 | 1.72 | 56.5 | Neo-adjuvant (N) | 2018-12-24 | 2018-12-25 | Fluorouracil + Folinic Acid Weekly | null | N | FLUOROURACIL | 101142786 |
| 20178747 | 20066586 | 1.6 | 75.9 | Palliative (P) | null | 2018-11-06 | Fluorouracil + Folinic Acid Weekly | N | N | FLUOROURACIL | 100002890 |
| 20178750 | 20066587 | 1.63 | 53.1 | Curative (C) | 2017-03-28 | 2017-03-31 | ECX | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101823832 |
| 20178754 | 20066588 | 1.81 | 80.8 | Curative (C) | 2018-03-09 | 2018-03-23 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101552708 |
| 20178767 | 20066589 | 1.56 | 80.8 | Neo-adjuvant (N) | 2016-06-15 | 2016-07-06 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100658107 |
| 20178768 | 20066590 | 1.73 | 79 | Adjuvant (A) | 2017-11-17 | 2017-12-15 | Fluorouricil + Folonic Acid (MdG) | 02 | N | FLUOROURACIL | 101482620 |
| 20178771 | 20066591 | 1.5 | 84 | Palliative (P) | 2016-12-29 | 2017-01-17 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100524238 |
| 20178772 | 20066592 | 1.82 | 72 | null | 2019-05-16 | 2019-06-05 | FLUOROURACIL | N | N | FLUOROURACIL | 101777451 |
| 20178775 | 20066593 | 1.8 | 70.3 | Adjuvant (A) | 2017-06-07 | 2017-06-22 | ECX | 02 | N | FLUOROURACIL | 101646501 |
| 20178776 | 20066594 | 1.77 | 98 | Palliative (P) | 2017-06-25 | 2017-06-25 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100478186 |
| 20178777 | 20066595 | 1.67 | 45 | Palliative (P) | 2017-04-02 | 2017-04-02 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100165395 |
| 20178780 | 20066596 | 1.63 | 89.4 | Neo-adjuvant (N) | 2017-03-29 | 2017-04-04 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101006554 |
| 20178785 | 20066597 | 1.8 | 74.3 | Palliative (P) | 2019-09-26 | 2019-09-26 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101171124 |
| 20178787 | 20066598 | 1.72 | 67 | Adjuvant (A) | 2016-10-14 | 2016-11-05 | FLUOROURACIL | 02 | null | FLUOROURACIL | 101551176 |
| 20178788 | 20066599 | 1.69 | 74.8 | Neo-adjuvant (N) | 2017-10-29 | 2017-11-15 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101533272 |
| 20178794 | 20066600 | 1.76 | 113 | Neo-adjuvant (N) | 2016-08-24 | 2016-09-01 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101327306 |
| 20178800 | 20066601 | 1.58 | 69.7 | Neo-adjuvant (N) | 2017-09-06 | 2017-09-09 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 100185759 |
| 20178801 | 20066602 | 1.77 | 68.2 | Adjuvant (A) | 2019-03-26 | 2019-04-11 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 100908047 |
| 20178804 | 20066603 | 1.58 | 71.6 | Adjuvant (A) | 2019-12-18 | 2019-12-26 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 100119956 |
| 20178807 | 20066604 | 1.68 | 60 | Neo-adjuvant (N) | 2018-12-19 | 2018-12-28 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100929691 |
| 20178810 | 20066605 | 1.82 | 72.6 | Neo-adjuvant (N) | 2019-11-01 | 2019-11-08 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100020256 |
| 20178811 | 20066606 | 1.73 | 71.6 | Neo-adjuvant (N) | 2018-01-27 | 2018-01-28 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100548884 |
| 20178823 | 20066607 | 1.74 | 49.2 | Palliative (P) | 2016-12-07 | 2016-12-14 | FLUOROURACIL | 02 | N | FLUOROURACIL | 100456280 |
| 20178835 | 20066608 | 1.81 | 70 | Palliative (P) | 2016-03-17 | 2016-03-31 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100444158 |
| 20178837 | 20066609 | 1.57 | 65 | null | 2016-07-18 | 2016-08-02 | FLUOROURACIL | 02 | N | FLUOROURACIL | 100728723 |
| 20178841 | 20066610 | 1.68 | 101.8 | Adjuvant (A) | 2016-02-27 | 2016-03-12 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 100247349 |
| 20178843 | 20066611 | 1.68 | 112.5 | Neo-adjuvant (N) | 2016-06-28 | 2016-07-14 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101768683 |
| 20178845 | 20066612 | 1.74 | 76.8 | Palliative (P) | 2019-09-27 | 2019-10-05 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101339394 |
| 20178853 | 20066613 | 1.77 | 81 | Adjuvant (A) | 2016-05-09 | 2016-05-09 | FLUOROURACIL | 02 | N | FLUOROURACIL | 101127753 |
| 20178854 | 20066614 | 1.5 | 56.7 | Neo-adjuvant (N) | 2018-04-21 | 2018-05-12 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101285410 |
| 20178855 | 20066615 | 1.65 | 89.2 | Neo-adjuvant (N) | 2018-08-31 | 2018-09-15 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101049570 |
| 20178862 | 20066616 | 1.76 | 74.3 | Curative (C) | 2017-10-21 | 2017-10-22 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101025767 |
| 20178863 | 20066617 | 1.66 | 55.8 | Adjuvant (A) | 2019-09-22 | 2019-09-30 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 100995124 |
| 20178865 | 20066618 | 1.49 | 61.8 | Adjuvant (A) | 2019-07-16 | 2019-07-17 | Fluorouracil + Folinic Acid Weekly | 2 | N | FLUOROURACIL | 100649554 |
| 20178871 | 20066619 | 1.9 | 80.9 | Neo-adjuvant (N) | 2018-08-28 | 2018-09-21 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100440358 |
| 20178872 | 20066620 | 1.62 | 78.2 | Palliative (P) | 2020-01-01 | 2020-01-08 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100731509 |
| 20178886 | 20066621 | 1.55 | 73 | Adjuvant (A) | 2019-10-23 | 2019-11-20 | Fluorouracil + Folinic Acid Weekly | N | N | FLUOROURACIL | 100234243 |
| 20178905 | 20066622 | 1.8 | 102 | Neo-adjuvant (N) | 2016-08-12 | 2016-08-14 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100951181 |
| 20178911 | 20066623 | 1.87 | 108 | Adjuvant (A) | 2017-07-30 | 2017-08-13 | FLUOROURACIL | 02 | N | FLUOROURACIL | 101500141 |
| 20178912 | 20066624 | 1.49 | 67.6 | Adjuvant (A) | 2017-03-18 | 2017-03-27 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 100133969 |
| 20178914 | 20066625 | 1.7 | 54 | Adjuvant (A) | 2016-10-14 | 2016-10-14 | Fluorouricil + Folonic Acid (MdG) | 02 | N | FLUOROURACIL | 101782636 |
| 20178915 | 20066626 | 1.63 | 69 | Curative (C) | 2018-01-12 | 2018-01-23 | Fluorouricil + Folonic Acid (MdG) | N | N | FLUOROURACIL | 101794588 |
| 20178923 | 20066627 | 1.7 | 62.8 | Neo-adjuvant (N) | 2016-05-14 | 2016-05-23 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101606907 |
| 20178925 | 20066628 | 1.58 | 74.9 | Neo-adjuvant (N) | 2019-03-27 | 2019-04-10 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101196949 |